Clinical research as a critical component of epidemic response: the case of PREVAIL in Liberia
Lancet Glob Health
.
2023 Mar;11(3):e321-e323.
doi: 10.1016/S2214-109X(23)00040-2.
Authors
Mosoka P Fallah
1
,
H Clifford Lane
2
,
Elizabeth S Higgs
2
,
Stephen B Kennedy
3
,
Moses B F Massaquoi
3
,
Mark W S Kieh
3
,
James D Neaton
4
,
Lisa E Hensley
5
,
Laura McNay
2
,
Wissedi Njoh
2
,
Jestina Doe-Anderson
2
Affiliations
1
PREVAIL, Monrovia, Liberia; Refuge Place International, Monrovia, Liberia. Electronic address:
[email protected]
.
2
PREVAIL, Monrovia, Liberia; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
3
PREVAIL, Monrovia, Liberia.
4
PREVAIL, Monrovia, Liberia; Division of Clinical Research, University of Minnesota, Minneapolis, MN, USA.
5
Food and Drug Administration, Silver Spring, MD, USA.
PMID:
36796971
DOI:
10.1016/S2214-109X(23)00040-2
No abstract available
MeSH terms
Epidemics*
Hemorrhagic Fever, Ebola* / epidemiology
Humans
Liberia / epidemiology